Odyssey Health, Inc. Net Income (Loss) Available to Common Stockholders, Diluted
Odyssey Health, Inc. (ODYY) reported Net Income (Loss) Available to Common Stockholders, Diluted of $1.24 million for the 3-month period ending 2026-04-30, per its 10-Q filed 2026-06-12.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted · last filed 2026-06-12
- Odyssey Health, Inc. net income (loss) available to common stockholders, diluted for the quarter ending 2026-04-30 was $1.24M.
- Odyssey Health, Inc. net income (loss) available to common stockholders, diluted for the quarter ending 2025-04-30 was -$251.74K.
- Odyssey Health, Inc. net income (loss) available to common stockholders, diluted for the quarter ending 2025-01-31 was -$220.13K, a 101.64% decline year-over-year.
- Odyssey Health, Inc. net income (loss) available to common stockholders, diluted for the quarter ending 2024-04-30 was -$842.34K.
| Period end | Net Income (Loss) Available to Common Stockholders, Diluted 3 month | Net Income (Loss) Available to Common Stockholders, Diluted 6 month | Net Income (Loss) Available to Common Stockholders, Diluted 9 month |
|---|---|---|---|
| 2026-04-30 | $1.24M 10-Q · filed 2026-06-12 | -$3.30M 10-Q · filed 2026-06-12 | |
| 2025-04-30 | -$251.74K 10-Q · filed 2026-06-12 | -$471.87K derived: sum of 2 quarters · filed 2026-06-12 | -$1.49M 10-Q · filed 2026-06-12 |
| 2025-01-31 | -$220.13K 10-Q · filed 2025-03-14 | -$1.24M 10-Q · filed 2025-03-14 | |
| 2024-04-30 | -$842.34K 10-Q · filed 2025-06-13 | $12.58M derived: sum of 2 quarters · filed 2025-06-13 | $12.33M 10-Q · filed 2025-06-13 |
| 2024-01-31 | $13.42M 10-Q · filed 2025-03-14 | $13.07M 10-Q · filed 2025-03-14 | |
| 2023-04-30 | -$1.28M 10-Q · filed 2024-06-14 | -$2.96M derived: sum of 2 quarters · filed 2024-06-14 | -$5.11M 10-Q · filed 2024-06-14 |
| 2023-01-31 | -$1.67M 10-Q · filed 2024-03-22 | -$3.82M 10-Q · filed 2024-03-22 |